Concurrent Session: Innovations in Supply Chain and CGT Operations|Cell and Gene Therapies (CGTs) are a growing field with its own set of challenges. The science of these innovative therapies is incredible, but so are the logistics and costs around supply chain and process efficiency. The sheer number of systems in these facilities requires a great deal of material that can create material/process/personnel/waste flows that can lead to inefficiency and increase the Cost of Goods (COG). In addition, supply disruptions during the COVID-19 pandemic have exposed many vulnerabilities across our supply chains for drugs and medical devices. Implementing an efficient and flexible supply chain, is critical. In this session, the presenters will use their design, operational and technology experience to lay out some of these challenges specific to CGT and demonstrate how proper design, materials planning and decentralized supply chain management can, increase flexibility, lower the cost of goods and improve the efficiency of getting medicine into the right hands at the right time.